Show simple item record

dc.contributor.authorLin, Qin
dc.contributor.authorYang, Rongshui
dc.contributor.authorSun, Long
dc.contributor.author孙龙
dc.contributor.authorChen, Shanyu
dc.contributor.authorWu, Hua
dc.date.accessioned2013-03-04T08:09:06Z
dc.date.available2013-03-04T08:09:06Z
dc.date.issued2012-08
dc.identifier.citationCANCER INVESTIGATION,2012,30(7):528-536zh_CN
dc.identifier.issn0735-7907
dc.identifier.urihttp://dx.doi.org/10.3109/07357907.2012.691193
dc.identifier.uriWOS:000306421800005
dc.identifier.urihttps://dspace.xmu.edu.cn/handle/2288/15047
dc.description.abstractWe used serial F-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) to evaluate tumors' maximum standardized uptake value (SUVmax) before, during, and after radiotherapy to explore the biological behavior of and response to radiation therapy in various subtypes of nasopharyngeal carcinoma (NPC). Sixty-one patients with pathologically diagnosed NPC were prospectively enrolled into the study. WHO type IIB disease had a higher initial SUVmax and more significant biological response at the primary site as compared with type IIA subtype. The two subtypes of WHO type II NPC may significantly differ in their biological behavior and response to radiotherapy.zh_CN
dc.description.sponsorshipMajor Projects of Fujian Natural Science Foundation [2008-59-11]; Youth Projects of Fujian Provincial Health Bureau [2008-1-51]zh_CN
dc.language.isoenzh_CN
dc.publisherINFORMA HEALTHCAREzh_CN
dc.subjectNasopharyngeal carcinomazh_CN
dc.subjectF-18-fluorodeoxyglucose positron emission tomographyzh_CN
dc.subjectRadiotherapyzh_CN
dc.subjectHistologyzh_CN
dc.titleBiological Response of Nasopharyngeal Carcinoma to Radiation Therapy: A Pilot Study Using Serial F-18-FDG PET/CT Scanszh_CN
dc.typeArticlezh_CN


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record